Nahdi Medical Company

4164

SA15HG521213

Drug Retailers

Market Closed - Saudi Arabian S.E. Other stock markets 12:20:00 22/01/2026 GMT			5-day change	1st Jan Change
93.20 ^SAR	+1.30%		+0.38%	-1.89%

11-18	Kepler Cheuvreux Reduces Nahdi Medical's PT, Affirms Buy Rating	MT
11-03	HSBC Trims Nahdi Medical PT, Affirms Buy Rating	MT

HSBC Trims Nahdi Medical PT, Affirms Buy Rating

Published on 11/03/2025 at 01:41 pm GMT

MT Newswires

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Nahdi Medical Company

11-18	Kepler Cheuvreux Reduces Nahdi Medical's PT, Affirms Buy Rating	MT
11-03	HSBC Trims Nahdi Medical PT, Affirms Buy Rating	MT
29/10/25	Nahdi Medical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
29/10/25	Al Nahdi Medical Q3 profit SAR 161.2 million	RE
29/10/25	Nahdi Medical's Q3 Net Profit Falls; Revenue Up	MT
10/10/25	Nahdi Medical Launches New Prescription Service in Saudi Arabia	MT
06/10/25	SNB Capital Reduces Nahdi Medical PT, Affirms Neutral Rating	MT
01/10/25	Citi Raises Nahdi Medical's PT, Keeps Neutral Rating	MT
01/10/25	HSBC Lifts Nahdi Medical PT, Maintains Buy Rating	MT
30/09/25	Nahdi Medical to Launch Prescription Dispensing Services	MT
30/09/25	Nahdi Medical Company Announces Launch of "Wasfaty" Prescription Dispensing Services in Collaboration with the National Unified Procurement Company	CI
29/09/25	EFG-Hermes Brokerage Upgrades Nahdi Medical to Buy	MT
09/09/25	ANB Capital Kicks Off Nahdi Medical Coverage at Neutral	MT
26/08/25	JP Morgan Reduces Nahdi Medical's PT, Reiterates Neutral Rating	MT
19/08/25	United Securities Lifts Nahdi Medical PT, Maintains Buy Rating	MT
18/08/25	MIDEAST STOCKS-Gulf shares mixed on Fed rate cut uncertainty	RE
13/08/25	MIDEAST STOCKS-Gulf bourses mixed on weaker corporate earnings, Fed rate cut hopes	RE
02/08/25	Nahdi Medical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
01/08/25	HSBC Trims Nahdi Medical's PT, Keeps Buy Rating	MT
30/07/25	MIDEAST STOCKS-Major Gulf markets ease as earnings underwhelm	RE
30/07/25	Nahdi Medical H1 dividend per share SAR 2.60	RE
30/07/25	Al Nahdi Medical Q2 net profit SAR 238.4 million	RE
30/07/25	Nahdi Medical's H1 Net Profit, Revenue Climb	MT
30/07/25	Nahdi Medical Company Announces Cash Dividend for the First Half of 2025, Payable on August 26, 2025	CI
12/06/25	JP Morgan Lifts Nahdi Medical's PT, Maintains Neutral Rating	MT

Al Nahdi Medical Company SJSC is a Saudi Arabia-based company, which is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. The Company operates two segments: The Front Shop and Pharma. The Company also operates specialized medical clinics through one of its subsidiaries. The Companyâs subsidiaries include Nahdi Care Limited Company, Al Sakhaa Golden Trading and Contracting Company and Nahdi Investment CO. L.L.C. The Company operates approximately 1120 pharmacies in the Kingdom of Saudi Arabia and the United Arab Emirates.

Employees

6,182

Sector

Drug Retailers

Calendar

03-15 - Q4 2025 Earnings Release (Projected)

More about the company